GCT Q1 2026 Earnings Strong EPS Beat Overshadows Stock Slight Decline ERAS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Climbs BILL Q1 2026 Earnings EPS Surpasses Estimates by Nearly 20 on Operational Discipline APVO Q1 2026 Earnings EPS Miss Widens as Revenue Remains Absent MBX Q1 2026 Earnings Narrower Loss Exceeds Expectations Amid Clinical Development Progress CIMN Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Lower